Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Ilyang Pharm (007570)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13,860 +60    +0.43%
30/04 - Closed. Currency in KRW ( Disclaimer )
  • Volume: 22,962
  • Bid/Ask: 13,860 / 13,870
  • Day's Range: 13,780 - 13,960
Type:  Equity
Market:  South Korea
ISIN:  KR7007570005 
Ilyang Pharm 13,860 +60 +0.43%

007570 Balance Sheet

 
Assess the latest Ilyang Pharm balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 007570 Annual Report data, financial summaries and charts are available for Ilyang Pharm investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 159066.39 176056.23 148525.74 146183.46
Cash and Short Term Investments 19760.76 16408.94 14783.09 14951.63
Cash - - - -
Cash & Equivalents 9484.95 9353.09 10178.7 9255.64
Short Term Investments 10275.8 7055.86 4604.39 5695.99
Total Receivables, Net 69004.27 77263.24 57349.86 57660.86
Accounts Receivables - Trade, Net 62701.32 70725.46 51444.4 51773.35
Total Inventory 61724.68 72977.72 70807.46 63609.86
Prepaid Expenses 186.42 161.92 224.02 150.41
Other Current Assets, Total 8390.28 9244.41 5361.31 9810.71
Total Assets 459455.97 489223.78 461122.19 445539.17
Property/Plant/Equipment, Total - Net 199478.04 197380.49 196707.58 198533.5
Property/Plant/Equipment, Total - Gross 200401.88 198127.87 197378.66 199021.4
Accumulated Depreciation, Total -923.84 -747.38 -671.08 -487.9
Goodwill, Net - - - -
Intangibles, Net 4371.23 4497.99 4505.57 4657.87
Long Term Investments 4340.15 18793.31 18666.79 2257.6
Note Receivable - Long Term 6302.94 6537.78 5905.46 5887.51
Other Long Term Assets, Total 21046.35 21637.43 21640.62 21617.67
Other Assets, Total 82540.29 82873.07 94499.2 93744.76
Total Current Liabilities 173674.35 197272.54 174942.99 172648.79
Accounts Payable 31495.24 - 27899.26 30522.1
Payable/Accrued - - - -
Accrued Expenses 398.44 - 342.66 310.26
Notes Payable/Short Term Debt 78248.48 90677.78 93278.02 87974.32
Current Port. of LT Debt/Capital Leases 522.11 2000 2463.27 2445.18
Other Current liabilities, Total 63010.09 104594.76 50959.78 51396.93
Total Liabilities 196428.26 217673.62 195783.6 190558.82
Total Long Term Debt 6339.24 - 610.82 543.26
Long Term Debt 6000 - - -
Capital Lease Obligations 339.24 - 610.82 543.26
Deferred Income Tax 9042.51 11621.72 11654.47 8992.48
Minority Interest 36070.91 36301.61 35276.33 35880.26
Other Liabilities, Total -191195.71 -210877.8 -119979.03 -205454.61
Total Equity 263027.7 271550.16 265338.59 254980.34
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net 1112.7 1112.7 1112.7 1112.7
Common Stock, Total 47714.16 47714.16 47714.16 47714.16
Additional Paid-In Capital 78441.23 78424.11 78464.85 78491.22
Retained Earnings (Accumulated Deficit) 53652.55 61032.12 56199.59 41951.78
Treasury Stock - Common -11920.78 -11852.08 -11625.55 -9969.1
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 94027.84 95119.16 93472.84 95679.58
Total Liabilities & Shareholders' Equity 459455.97 489223.78 461122.19 445539.17
Total Common Shares Outstanding 17.97 17.97 18.04 18.09
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

007570 Price Commentary

Write your thoughts about Ilyang Pharm
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email